Literature DB >> 9345045

Regulated expression of the Eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis.

H C Aasheim1, L W Terstappen, T Logtenberg.   

Abstract

Members of the large Eph family of receptor tyrosine kinases (RTKs) display temporally and spatially restricted expression patterns during embryogenesis, suggesting a role in various developmental processes. We have begun to investigate the expression of members of this receptor family during human hematopoiesis, in particular B lymphopoiesis. Expression of Eph RTKs in cells of the B-lymphoid lineage was assessed by using degenerate oligonucleotide primers based on stretches of conserved nucleic acid sequences in members of the Eph family. First, the content of Eph-family RTKs was assessed in freshly sorted fetal bone marrow pro-B cells. This population was found to harbor transcripts of the Hek8 and Hek11 members of this gene family. Subsequent analysis of expression of these genes in B cells representing various differentiation and ontogenic stages showed that the Hek8 transcript is constitutively present in all fetal and adult B-lineage cells, with high levels of expression in peripheral blood B cells. In contrast, the Hek11 transcript was exclusively found in fetal bone marrow pro-B cells and pre-B cells, but not in more mature fetal B-lineage cells. All adult B-lineage cells, from early pro-B cells to end-stage plasma cells, lacked Hek11 transcripts. The developmentally regulated expression of Hek11 during fetal B lymphopoiesis suggests a role for this gene in pre/pro-B cell expansion and/or differentiation and defines a difference in progenitor B cell populations isolated from fetal versus adult human bone marrow.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9345045

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  EphB6-null mutation results in compromised T cell function.

Authors:  Hongyu Luo; Guang Yu; Johanne Tremblay; Jiangping Wu
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

3.  Modeling the impact of alcohol on cortical development in a dish: strategies from mapping neural stem cell fate.

Authors:  Rajesh C Miranda; Daniel R Santillano; Cynthia Camarillo; Douglas Dohrman
Journal:  Methods Mol Biol       Date:  2008

4.  Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.

Authors:  D W Dawson; J S Hong; R R Shen; S W French; J J Troke; Y-Z Wu; S-S Chen; D Gui; M Regelson; Y Marahrens; H C Morse; J Said; C Plass; M A Teitell
Journal:  Oncogene       Date:  2007-01-29       Impact factor: 9.867

5.  ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias.

Authors:  Hiroshi Nakanishi; Tatsuya Nakamura; Eli Canaani; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

6.  A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a.

Authors:  Eivind F Finne; Else Munthe; Hans-Christian Aasheim
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

7.  Differential gene expression in the EphA4 knockout spinal cord and analysis of the inflammatory response following spinal cord injury.

Authors:  Kathryn M Munro; Victoria M Perreau; Ann M Turnley
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

8.  EphA receptors and ephrin-A ligands are upregulated by monocytic differentiation/maturation and promote cell adhesion and protrusion formation in HL60 monocytes.

Authors:  Midori Mukai; Norihiko Suruga; Noritaka Saeki; Kazushige Ogawa
Journal:  BMC Cell Biol       Date:  2017-08-29       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.